In April 2008, certolizumab pegol (Cimzia; UCB), a tumour-necrosis factor blocker, was approved by the US FDA for the treatment of adult patients with moderate-to-severe Crohn's disease who have ...

Mechanism of action describes the process by which a molecule, such as a drug, functions to produce a pharmacological effect. A drug’s mechanism of action may refer to its effects on a ...

Researchers have discovered a neural mechanism for memory integration that stretches across both time and personal experience. Mount Sinai researchers have discovered for the first time a neural ...

Get detailed information on Certolizumab, including pronunciation, uses, dosage guidelines, indications, and instructions on how and when to take it and when to avoid it. The updated prescription ...

Most notably, NICE is set to issue guidance on Novartis' Cosentyx (secukinumab) and USB Cimzia (certolizumab) in the same indication in February 2017. Discover how AI is transforming the pharma ...

Rheumatoid arthritis flares can be unpredictable—and they can last anywhere between a day to a year if left untreated. Home remedies like acupuncture and medication can help calm flares. For ...

Medically reviewed by Mary Choy, PharmD Joint pain can be caused by a number of biological, psychological, and social factors ...

Key Laboratory of Advanced Energy Materials Chemistry, Ministry of Education State Key Laboratory of Advanced Chemical Power Sources Collaborative Innovation Center of Chemical Science and Engineering ...

injection, 50 mg every month Certolizumab Cimzia® Human, pegylated monoclonal antibody sc. injection, 200–400 mg every 2–4 weeks OLT 3 (DE029) Healthy male and female subjects 120 25 mg/ml sc.